Chen, Dazhong <br/><br/>
Codelivery of doxorubicin and elacridar to target both liver cancer cells and stem cells by polylactide-co-glycolide/d-alpha-tocopherol polyethylene glycol 1000 succinate nanoparticles.  [electronic resource] 

 -  International journal of nanomedicine  2018 
 - 6855-6870 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1178-2013 
<br/><br/><label>Standard No.: </label>10.2147/IJN.S181928  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acridines--administration & dosage<br/>Animals<br/>Carcinoma, Hepatocellular--drug therapy<br/>Cell Death--drug effects<br/>Doxorubicin--administration & dosage<br/>Drug Delivery Systems<br/>Drug Synergism<br/>Endocytosis--drug effects<br/>Hep G2 Cells<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Mice, Nude<br/>Nanoparticles--administration & dosage<br/>Neoplastic Stem Cells--drug effects<br/>Polyesters--chemistry<br/>Polyethylene Glycols--chemistry<br/>Rats, Sprague-Dawley<br/>Stem Cell Transplantation<br/>Stem Cells--cytology<br/>Subcutaneous Tissue--drug effects<br/>Tetrahydroisoquinolines--administration & dosage<br/>Tissue Distribution<br/>Tumor Stem Cell Assay<br/>Vitamin E--chemistry